Beth Israel Deaconess Medical Center: Breast Neoplasms trials

The registry lists 22 Breast Neoplasms studies with Beth Israel Deaconess Medical Center as lead sponsor. 1 are open to participants now and 8 have results posted.

Early Phase 1 1Phase 1 6Phase 2 7No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast CancersRecruitingNCT06896474Not applicable
• Alcohol and Breast Cancer (ABC) TrialCompletedNCT05423730Not applicableResults posted
• Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer ScreeningCompletedNCT03495115Not applicableResults posted
• Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer ScreeningCompletedNCT03482557Not applicableResults posted
• Real-Time Assessment Of Breast Cancer Surgical Specimen Margins With Nonlinear MicroscopyTerminatedNCT02926729Not applicableResults posted
• Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCaCompletedNCT01670500Phase 2Results posted
• Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast CancerCompletedNCT01299038Phase 2Results posted
• Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12TerminatedNCT00622401Phase 1/2Results posted
• Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast CancerCompletedNCT00458237Phase 1/2Results posted
• Testing Conversation Aid in PracticeCompletedNCT06011434
• Olaparib In Metastatic Breast CancerActive, not recruitingNCT03344965Phase 2
• Breast Cancer Risk Assessment in Women Aged 40-49CompletedNCT03180086Not applicable
• A Breast Cancer Treatment Decision Aid for Women Aged 70 and OlderTerminatedNCT02823262Not applicable
• Imaging Markers of Subclinical Cardiotoxicity in Breast CancerCompletedNCT02666378
• Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast CancerTerminatedNCT02275871Not applicable
• Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast CancerCompletedNCT01468649Early Phase 1
• Tissue Oxygenation Measurements With Modulated Light (S-FLARE)CompletedNCT01116297Phase 1
• Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast CancerCompletedNCT00721370Phase 1
• Efficacy and Safety of 500mg of FulvestrantActive, not recruitingNCT00585507Phase 2
• Study of Fine Art Photographs and Visualization Tapes to Improve Surgical Recovery in Breast CancerTerminatedNCT00179634Not applicable
• Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast CancerWithdrawnNCT00006123Phase 1/2
• Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell TransplantationStatus unknownNCT00003412Phase 1